Published in Biol Psychiatry on January 15, 2002
Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry (2002) 10.34
Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry (2003) 7.11
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci (2011) 4.88
The addicted human brain: insights from imaging studies. J Clin Invest (2003) 3.91
The hidden island of addiction: the insula. Trends Neurosci (2008) 3.28
Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage (2003) 2.75
Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry. J Neurol Neurosurg Psychiatry (2002) 2.12
The neurocircuitry of addiction: an overview. Br J Pharmacol (2008) 2.11
A role for the prefrontal cortex in stress- and cocaine-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) (2002) 2.08
Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain (2011) 2.00
Adolescent impulsivity phenotypes characterized by distinct brain networks. Nat Neurosci (2012) 1.98
The role of orbitofrontal cortex in drug addiction: a review of preclinical studies. Biol Psychiatry (2007) 1.89
Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity. Neuroimage (2010) 1.84
Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging study. Psychopharmacology (Berl) (2005) 1.84
The effects of cocaine: a shifting target over the course of addiction. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.83
Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals. Biol Psychiatry (2008) 1.73
Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects. Ann N Y Acad Sci (2008) 1.69
Extinction training regulates neuroadaptive responses to withdrawal from chronic cocaine self-administration. Learn Mem (2004) 1.63
Insight into the relationship between impulsivity and substance abuse from studies using animal models. Alcohol Clin Exp Res (2010) 1.62
Brain macrostructural and microstructural abnormalities in cocaine dependence. Drug Alcohol Depend (2007) 1.59
A somatic marker theory of addiction. Neuropharmacology (2008) 1.59
The differential relationship between cocaine use and marijuana use on decision-making performance over repeat testing with the Iowa Gambling Task. Drug Alcohol Depend (2007) 1.54
What's new in neuroimaging methods? Ann N Y Acad Sci (2009) 1.53
The impact of orbitofrontal dysfunction on cocaine addiction. Nat Neurosci (2012) 1.50
Disorders of compulsivity: a common bias towards learning habits. Mol Psychiatry (2014) 1.48
Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint? Ann N Y Acad Sci (2010) 1.46
D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning. Neuropsychopharmacology (2010) 1.46
Reduced interhemispheric resting state functional connectivity in cocaine addiction. Biol Psychiatry (2011) 1.45
Acute effects of cocaine on the neurobiology of cognitive control. Philos Trans R Soc Lond B Biol Sci (2008) 1.38
Aberrant paralimbic gray matter in criminal psychopathy. J Abnorm Psychol (2011) 1.37
Prefrontal cortex and drug abuse vulnerability: translation to prevention and treatment interventions. Brain Res Rev (2010) 1.34
The insula: a critical neural substrate for craving and drug seeking under conflict and risk. Ann N Y Acad Sci (2014) 1.33
Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments. Neuropsychopharmacology (2007) 1.31
Cumulative adversity and smaller gray matter volume in medial prefrontal, anterior cingulate, and insula regions. Biol Psychiatry (2012) 1.29
Extended daily access to cocaine results in distinct alterations in Homer 1b/c and NMDA receptor subunit expression within the medial prefrontal cortex. Synapse (2009) 1.27
Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse? Neuron (2008) 1.27
Frontal hyperconnectivity related to discounting and reversal learning in cocaine subjects. Biol Psychiatry (2011) 1.26
Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals. Neuroimage (2010) 1.23
Gray-matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine. Drug Alcohol Depend (2012) 1.20
Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction. Neurosci Biobehav Rev (2010) 1.19
Chronic cocaine self-administration in rhesus monkeys: impact on associative learning, cognitive control, and working memory. J Neurosci (2011) 1.15
Functional MRI and response inhibition in children exposed to cocaine in utero. Preliminary findings. Dev Neurosci (2009) 1.14
Gene x disease interaction on orbitofrontal gray matter in cocaine addiction. Arch Gen Psychiatry (2011) 1.14
Reductions in brain 5-HT1B receptor availability in primarily cocaine-dependent humans. Biol Psychiatry (2013) 1.14
Arg kinase regulates prefrontal dendritic spine refinement and cocaine-induced plasticity. J Neurosci (2012) 1.11
Review. Evidence-based treatments of addiction. Philos Trans R Soc Lond B Biol Sci (2008) 1.07
Combined neuroimaging, neurocognitive and psychiatric factors to predict alcohol consumption following treatment for alcohol dependence. Alcohol Alcohol (2008) 1.06
Neurobiological processes in adolescent addictive disorders. Am J Addict (2008) 1.06
Right ventromedial prefrontal cortex: a neuroanatomical correlate of impulse control in boys. Soc Cogn Affect Neurosci (2008) 1.06
Elevated gray and white matter densities in cocaine abstainers compared to current users. Psychopharmacology (Berl) (2011) 1.04
Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. Pharmacol Ther (2012) 1.04
Involvement of the lateral orbitofrontal cortex in drug context-induced reinstatement of cocaine-seeking behavior in rats. Eur J Neurosci (2009) 1.04
Basal ganglia plus insula damage yields stronger disruption of smoking addiction than basal ganglia damage alone. Nicotine Tob Res (2013) 1.02
Distinctive personality traits and neural correlates associated with stimulant drug use versus familial risk of stimulant dependence. Biol Psychiatry (2012) 1.02
Lower glutamate levels in rostral anterior cingulate of chronic cocaine users - A (1)H-MRS study using TE-averaged PRESS at 3 T with an optimized quantification strategy. Psychiatry Res (2009) 1.02
Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants? Neurosci Biobehav Rev (2012) 1.01
Temporal decision-making: insights from cognitive neuroscience. Front Behav Neurosci (2009) 1.01
Prefrontal cortical regulation of drug seeking in animal models of drug relapse. Curr Top Behav Neurosci (2010) 1.01
Diffusion tensor imaging of cocaine-treated rodents. Psychiatry Res (2009) 0.99
Altered neural cholinergic receptor systems in cocaine-addicted subjects. Neuropsychopharmacology (2010) 0.99
Aberrant paralimbic gray matter in incarcerated male adolescents with psychopathic traits. J Am Acad Child Adolesc Psychiatry (2013) 0.99
Assessing white matter integrity as a function of abstinence duration in former cocaine-dependent individuals. Drug Alcohol Depend (2010) 0.98
The somatic marker theory in the context of addiction: contributions to understanding development and maintenance. Psychol Res Behav Manag (2015) 0.97
Functional, structural, and emotional correlates of impaired insight in cocaine addiction. JAMA Psychiatry (2014) 0.97
Differential roles of the prefrontal cortical subregions and basolateral amygdala in compulsive cocaine seeking and relapse after voluntary abstinence in rats. Eur J Neurosci (2013) 0.96
Sex differences in medial and lateral orbitofrontal cortex hypoperfusion in cocaine-dependent men and women. Gend Med (2006) 0.96
Loss of laterality in chronic cocaine users: an fMRI investigation of sensorimotor control. Psychiatry Res (2010) 0.96
Neuropsychiatric effects of cocaine use disorders. J Natl Med Assoc (2005) 0.95
Compulsivity in anorexia nervosa: a transdiagnostic concept. Front Psychol (2014) 0.95
Dissociated grey matter changes with prolonged addiction and extended abstinence in cocaine users. PLoS One (2013) 0.95
Structural and behavioral correlates of abnormal encoding of money value in the sensorimotor striatum in cocaine addiction. Eur J Neurosci (2012) 0.95
HIV and recent illicit drug use interact to affect verbal memory in women. J Acquir Immune Defic Syndr (2013) 0.95
Reward, interrupted: Inhibitory control and its relevance to addictions. Neuropharmacology (2013) 0.94
A VBM study demonstrating 'apparent' effects of a single dose of medication on T1-weighted MRIs. Brain Struct Funct (2013) 0.94
Insula and orbitofrontal cortical morphology in substance dependence is modulated by sex. AJNR Am J Neuroradiol (2012) 0.94
Emotion, decision-making and substance dependence: a somatic-marker model of addiction. Curr Neuropharmacol (2006) 0.94
Glutamatergic plasticity in medial prefrontal cortex and ventral tegmental area following extended-access cocaine self-administration. Brain Res (2011) 0.94
Neural plasticity, human genetics, and risk for alcohol dependence. Int Rev Neurobiol (2010) 0.94
Event-Related Potential Study of Executive Dysfunctions in a Speeded Reaction Task in Cocaine Addiction. J Neurother (2008) 0.93
Evidence of temporal cortical dysfunction in rhesus monkeys following chronic cocaine self-administration. Cereb Cortex (2007) 0.91
Reduced insular volume in attention deficit hyperactivity disorder. Psychiatry Res (2012) 0.91
Deficits in cortical, diencephalic and midbrain gray matter in alcoholism measured by VBM: Effects of co-morbid substance abuse. Neuroimage Clin (2013) 0.90
A selective insular perfusion deficit contributes to compromised salience network connectivity in recovering alcoholic men. Biol Psychiatry (2013) 0.90
Neuroscience. To stop or not to stop? Science (2012) 0.90
The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals. Adv Pharmacol (2014) 0.90
Short and long access to cocaine self-administration activates tyrosine phosphatase STEP and attenuates GluN expression but differentially regulates GluA expression in the prefrontal cortex. Psychopharmacology (Berl) (2013) 0.89
Extended access to cocaine self-administration results in reduced glutamate function within the medial prefrontal cortex. Addict Biol (2012) 0.89
Effect of cocaine on structural changes in brain: MRI volumetry using tensor-based morphometry. Drug Alcohol Depend (2010) 0.89
Larger mid-dorsolateral prefrontal gray matter volume in young binge drinkers revealed by voxel-based morphometry. PLoS One (2014) 0.88
Higher media multi-tasking activity is associated with smaller gray-matter density in the anterior cingulate cortex. PLoS One (2014) 0.88
Prelimbic and infralimbic cortical regions differentially encode cocaine-associated stimuli and cocaine-seeking before and following abstinence. Eur J Neurosci (2014) 0.88
Abnormal fronto-limbic engagement in incarcerated stimulant users during moral processing. Psychopharmacology (Berl) (2016) 0.88
Pornography addiction - a supranormal stimulus considered in the context of neuroplasticity. Socioaffect Neurosci Psychol (2013) 0.88
Neuroanatomic comparison of bipolar adolescents with and without cannabis use disorders. J Child Adolesc Psychopharmacol (2008) 0.88
The reward-based eating drive scale: a self-report index of reward-based eating. PLoS One (2014) 0.88
Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society. Behav Pharmacol (2010) 0.87
Comorbid substance abuse and brain morphology in recent-onset psychosis. Eur Arch Psychiatry Clin Neurosci (2009) 0.87
Cue-induced reinstatement of cocaine seeking in the rat "conflict model": effect of prolonged home-cage confinement. Psychopharmacology (Berl) (2011) 0.87
Enhanced anxiety observed in cocaine withdrawn rats is associated with altered reactivity of the dorsomedial prefrontal cortex. PLoS One (2012) 0.86
An international consensus for assessing internet gaming disorder using the new DSM-5 approach. Addiction (2014) 8.38
What's in a word? Addiction versus dependence in DSM-V. Am J Psychiatry (2006) 8.22
A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology (2003) 3.66
A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology (2005) 3.53
Internet gaming disorder and the DSM-5. Addiction (2013) 3.46
Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA (2013) 3.25
Brain metabolic changes during cigarette craving. Arch Gen Psychiatry (2002) 3.16
Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry (2006) 3.06
The neurocircuitry of impaired insight in drug addiction. Trends Cogn Sci (2009) 3.01
DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry (2013) 2.89
Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsychopharmacology (2007) 2.73
Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. Am J Psychiatry (2007) 2.60
The status of disulfiram: a half of a century later. J Clin Psychopharmacol (2006) 2.48
Issues for DSM-V: should obesity be included as a brain disorder? Am J Psychiatry (2007) 2.48
A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry (2010) 2.34
Do research payments precipitate drug use or coerce participation? Drug Alcohol Depend (2005) 2.26
Arterial transit time imaging with flow encoding arterial spin tagging (FEAST). Magn Reson Med (2003) 2.25
Biological parametric mapping: A statistical toolbox for multimodality brain image analysis. Neuroimage (2006) 2.22
Prelude to passion: limbic activation by "unseen" drug and sexual cues. PLoS One (2008) 2.07
The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychopharmacol (2006) 2.00
Evidence of myocardial hibernation in the septic heart. Crit Care Med (2005) 1.94
Optimal number of pinholes in multi-pinhole SPECT for mouse brain imaging--a simulation study. Phys Med Biol (2005) 1.80
Drug treatment as HIV prevention: a research update. J Acquir Immune Defic Syndr (2010) 1.79
A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend (2004) 1.75
Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci (2011) 1.74
Effect of resting-state functional MR imaging duration on stability of graph theory metrics of brain network connectivity. Radiology (2011) 1.73
Telling truth from lie in individual subjects with fast event-related fMRI. Hum Brain Mapp (2005) 1.70
Review of the Diabetes Heart Study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications. Rev Diabet Stud (2010) 1.69
Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis. J Womens Health (Larchmt) (2008) 1.67
Higher magnitude cash payments improve research follow-up rates without increasing drug use or perceived coercion. Drug Alcohol Depend (2008) 1.67
Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. J Subst Abuse Treat (2006) 1.63
Comparing attentional bias to smoking cues in current smokers, former smokers, and non-smokers using a dot-probe task. Drug Alcohol Depend (2002) 1.56
SPECT imaging of herpes simplex virus type1 thymidine kinase gene expression by [(123)I]FIAU(1). Acad Radiol (2005) 1.55
Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend (2003) 1.50
Relating imaging indices of white matter integrity and volume in healthy older adults. Cereb Cortex (2007) 1.47
Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint? Ann N Y Acad Sci (2010) 1.46
Enhanced multisensory integration in older adults. Neurobiol Aging (2005) 1.46
Effects of varenicline on smoking cue–triggered neural and craving responses. Arch Gen Psychiatry (2011) 1.45
Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addict Behav (2002) 1.44
Effects of methylphenidate discontinuation on cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder. J Nucl Med (2002) 1.43
Semantic congruence is a critical factor in multisensory behavioral performance. Exp Brain Res (2004) 1.40
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry (2004) 1.39
Retrospective study: influence of menstrual cycle on cue-induced cigarette craving. Nicotine Tob Res (2004) 1.37
Small-animal SPECT and SPECT/CT: important tools for preclinical investigation. J Nucl Med (2008) 1.35
Naltrexone for heroin dependence treatment in St. Petersburg, Russia. J Subst Abuse Treat (2004) 1.35
Current status of co-occurring mood and substance use disorders: a new therapeutic target. Am J Psychiatry (2013) 1.33
DAT genotype modulates brain and behavioral responses elicited by cigarette cues. Neuropsychopharmacology (2008) 1.31
The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study. Drug Alcohol Depend (2009) 1.30
In vivo detection of stem cells grafted in infarcted rat myocardium. J Nucl Med (2005) 1.30
Head impact exposure in youth football: elementary school ages 9-12 years and the effect of practice structure. Ann Biomed Eng (2013) 1.29
Imaging stem cells implanted in infarcted myocardium. J Am Coll Cardiol (2006) 1.28
A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet (2003) 1.25
The effect of daily caffeine use on cerebral blood flow: How much caffeine can we tolerate? Hum Brain Mapp (2009) 1.24
Adaptive Interventions in Drug Court: A Pilot Experiment. Crim Justice Rev (2008) 1.22
Dietary caffeine consumption modulates fMRI measures. Neuroimage (2002) 1.21
Susceptibility contrast and arterial spin labeled perfusion MRI in cerebrovascular disease. J Neuroimaging (2003) 1.20
Diffusion anisotropy in the corpus callosum. AJNR Am J Neuroradiol (2002) 1.18
Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence. J Subst Abuse Treat (2007) 1.18
A potential role for GABA(B) agonists in the treatment of psychostimulant addiction. Alcohol Alcohol (2002) 1.17
Relationship between caffeine-induced changes in resting cerebral perfusion and blood oxygenation level-dependent signal. AJNR Am J Neuroradiol (2003) 1.17
A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Drug Alcohol Depend (2006) 1.17
Aging and the interaction of sensory cortical function and structure. Hum Brain Mapp (2009) 1.16
Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohort. Addict Biol (2011) 1.16
A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention. Alcohol Clin Exp Res (2008) 1.15
Systemic immune activation leads to neuroinflammation and sickness behavior in mice. Mediators Inflamm (2013) 1.14
Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry (2007) 1.14
Arterial spin-labeled MR perfusion imaging: clinical applications. Magn Reson Imaging Clin N Am (2009) 1.13
A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence. Addict Behav (2007) 1.11
Alcohol potentiates hepatitis C virus replicon expression. Hepatology (2003) 1.11
Relations between BOLD fMRI-derived resting brain activity and cerebral blood flow. PLoS One (2012) 1.11
A double-blind, placebo-controlled trial of modafinil for cocaine dependence. J Subst Abuse Treat (2012) 1.10
A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism. J Clin Psychopharmacol (2007) 1.10
Cross-modal deactivations during modality-specific selective attention. BMC Neurol (2008) 1.10
Measuring coercion to participate in research within a doubly vulnerable population: initial development of the coercion assessment scale. J Empir Res Hum Res Ethics (2010) 1.06
Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone. Addict Biol (2006) 1.06
Alcohol potentiates HIV-1 infection of human blood mononuclear phagocytes. Alcohol Clin Exp Res (2002) 1.06
Simplified quantification of small animal [18F]FDG PET studies using a standard arterial input function. Eur J Nucl Med Mol Imaging (2006) 1.05
Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence. Neuropsychopharmacology (2008) 1.05
Brain volumes, cognitive impairment, and conjugated equine estrogens. J Gerontol A Biol Sci Med Sci (2009) 1.05
Abnormal white matter integrity related to head impact exposure in a season of high school varsity football. J Neurotrauma (2014) 1.04
Cocaine dependence severity predicts outcome in outpatient detoxification from cocaine and alcohol. Am J Addict (2004) 1.03
A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence. Drug Alcohol Depend (2013) 1.03
Neural correlates of successful and unsuccessful verbal memory encoding. Brain Lang (2002) 1.03
The impact of temporal regularization on estimates of the BOLD hemodynamic response function: a comparative analysis. Neuroimage (2008) 1.00
A comparison of the effects of 6-beta naltrexol and naltrexone on the consumption of ethanol or sucrose using a limited-access procedure in rats. Pharmacol Biochem Behav (2002) 1.00
Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experiment. J Clin Psychiatry (2010) 0.99
Head impact exposure in youth football: high school ages 14 to 18 years and cumulative impact analysis. Ann Biomed Eng (2013) 0.99
Rationale for changes in DSM-5. J Stud Alcohol Drugs (2012) 0.98
Detecting smoking following smoking cessation treatment. Drug Alcohol Depend (2002) 0.98